X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (44739) 44739
Book Review (7615) 7615
Publication (2841) 2841
Book Chapter (389) 389
Conference Proceeding (241) 241
Dissertation (63) 63
Magazine Article (48) 48
Book / eBook (19) 19
Newsletter (14) 14
Web Resource (6) 6
Data Set (4) 4
Paper (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (37141) 37141
humans (30815) 30815
male (24331) 24331
female (20100) 20100
cardiac & cardiovascular systems (17291) 17291
middle aged (15112) 15112
echocardiography (11018) 11018
aged (10682) 10682
adult (10294) 10294
animals (9541) 9541
left-ventricular hypertrophy (9405) 9405
hypertension (9026) 9026
peripheral vascular disease (7157) 7157
hypertrophy (6546) 6546
risk factors (6541) 6541
heart (6297) 6297
abridged index medicus (6296) 6296
heart failure (5958) 5958
left ventricular hypertrophy (5643) 5643
hypertrophy, left ventricular - physiopathology (5349) 5349
cardiology (4621) 4621
blood pressure (4597) 4597
hypertension - physiopathology (4596) 4596
rats (4584) 4584
heart-failure (4498) 4498
electrocardiography (4446) 4446
mortality (4411) 4411
ventricular function, left (4083) 4083
hypertension - complications (3956) 3956
hypertrophy, left ventricular - etiology (3911) 3911
prognosis (3825) 3825
cardiomyopathy (3577) 3577
ventricular dysfunction, left - physiopathology (3490) 3490
hypertrophy, left ventricular - diagnostic imaging (3459) 3459
cardiovascular (3433) 3433
blood-pressure (3360) 3360
ventricular function, left - physiology (3222) 3222
disease (3189) 3189
myocardium - pathology (3184) 3184
time factors (3086) 3086
cardiovascular disease (3004) 3004
treatment outcome (2981) 2981
prospective studies (2851) 2851
adolescent (2848) 2848
hypertension - drug therapy (2826) 2826
medicine & public health (2798) 2798
prevalence (2743) 2743
follow-up studies (2703) 2703
stroke volume (2697) 2697
aged, 80 and over (2685) 2685
heart failure - physiopathology (2636) 2636
myocardial-infarction (2621) 2621
analysis (2609) 2609
physiology (2599) 2599
research (2532) 2532
diagnosis (2500) 2500
care and treatment (2422) 2422
mass (2387) 2387
dysfunction (2373) 2373
urology & nephrology (2361) 2361
myocardium - metabolism (2354) 2354
disease models, animal (2352) 2352
heart ventricles - diagnostic imaging (2310) 2310
ventricular dysfunction, left - diagnostic imaging (2286) 2286
risk (2269) 2269
predictive value of tests (2233) 2233
echocardiography, doppler (2217) 2217
mice (2207) 2207
pharmacology & pharmacy (2206) 2206
hypertrophy, left ventricular - diagnosis (2117) 2117
hypertrophy, left ventricular - pathology (2108) 2108
physiological aspects (2107) 2107
diastole (2079) 2079
medicine, general & internal (2065) 2065
health aspects (2034) 2034
fibrosis (2029) 2029
left-ventricular mass (2006) 2006
hypertrophy, left ventricular - complications (1997) 1997
cardiovascular diseases (1988) 1988
hemodynamics (1983) 1983
retrospective studies (1978) 1978
antihypertensive agents - therapeutic use (1963) 1963
left-ventricular dysfunction (1962) 1962
ventricular dysfunction, left - etiology (1957) 1957
child (1954) 1954
heart ventricles - physiopathology (1923) 1923
heart diseases (1914) 1914
blood pressure - drug effects (1877) 1877
blood pressure - physiology (1863) 1863
cardiac-hypertrophy (1860) 1860
diastolic function (1860) 1860
case-control studies (1844) 1844
heart attacks (1801) 1801
exercise (1795) 1795
magnetic resonance imaging (1789) 1789
heart ventricles - pathology (1767) 1767
cardiovascular system (1746) 1746
ultrasonography (1728) 1728
ventricular function, left - drug effects (1700) 1700
surgery (1689) 1689
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
OISE - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (42264) 42264
Russian (572) 572
German (502) 502
Spanish (462) 462
French (386) 386
Portuguese (208) 208
Chinese (167) 167
Italian (155) 155
Polish (149) 149
Japanese (148) 148
Turkish (65) 65
Korean (36) 36
Czech (32) 32
Serbian (28) 28
Hungarian (20) 20
Slovak (18) 18
Ukrainian (18) 18
Romanian (13) 13
Danish (11) 11
Croatian (9) 9
Dutch (6) 6
Norwegian (6) 6
Swedish (6) 6
Lithuanian (5) 5
Persian (5) 5
Bosnian (4) 4
Finnish (2) 2
Hebrew (2) 2
Slovenian (2) 2
Belarusian (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1998, ISBN 9780443063619, x, 209
Book
Journal of Clinical Investigation, ISSN 0021-9738, 11/2011, Volume 121, Issue 11, pp. 4393 - 4408
Journal Article
1999, Developments in cardiovascular medicine, ISBN 9780792360384, Volume 223., x, 182
Book
JOURNAL OF HYPERTENSION, ISSN 0263-6352, 01/2017, Volume 35, Issue 1, pp. 162 - 169
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 1993 - 12
Journal Article
Cell Metabolism, ISSN 1550-4131, 12/2015, Volume 22, Issue 6, pp. 1020 - 1032
Chronic kidney disease (CKD) is a worldwide public health threat that increases risk of death due to cardiovascular complications, including left ventricular... 
SIGNAL-TRANSDUCTION | MORTALITY | FACTOR FAMILY | KLOTHO | POINT MUTATION | TYROSINE KINASE | ENDOCRINOLOGY & METABOLISM | CHRONIC KIDNEY-DISEASE | CANCER PROGRESSION | EXPRESSION | FGF RECEPTOR | CELL BIOLOGY | Receptor, Fibroblast Growth Factor, Type 4 - metabolism | Humans | Glucuronidase - metabolism | Fibroblast Growth Factors - genetics | Male | Renal Insufficiency, Chronic - metabolism | Fibroblast Growth Factors - metabolism | Hypertrophy, Left Ventricular - pathology | HEK293 Cells | Receptor, Fibroblast Growth Factor, Type 4 - deficiency | Female | Receptor, Fibroblast Growth Factor, Type 4 - genetics | Disease Models, Animal | Phospholipase C gamma - metabolism | Mutagenesis, Site-Directed | Myocytes, Cardiac - cytology | Signal Transduction | Hypertrophy, Left Ventricular - metabolism | Mice, Inbred C57BL | NFATC Transcription Factors - metabolism | Cells, Cultured | Rats | Rats, Sprague-Dawley | Gene Knock-In Techniques | Mice, Knockout | Renal Insufficiency, Chronic - pathology | Animals | Glucuronidase - genetics | Myocytes, Cardiac - metabolism | Mice | Calcineurin - metabolism | Hypertension | Medical colleges | Chronic kidney failure | Heart enlargement | Stem cells | Physiological aspects | Fibroblast growth factors | Phospholipases | Drug discovery | T cells | Health aspects | Heart | Resveratrol | Development and progression | Kidney diseases | Cells | Index Medicus
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 10, pp. 901 - 909
Journal Article
Circulation, ISSN 0009-7322, 10/2003, Volume 108, Issue 15, pp. 1831 - 1838
Background - Elevated renin-angiotensin-aldosterone system activity correlates with left ventricular hypertrophy (LVH) and cardiovascular risk, but the... 
Hypertension | Blood pressure | Ventricles | Hypertrophy | blood pressure | CARDIAC & CARDIOVASCULAR SYSTEMS | hypertrophy | LOSARTAN INTERVENTION | CARDIOVASCULAR MORBIDITY | ANGIOTENSIN-CONVERTING ENZYME | BLOOD-PRESSURE | ventricles | RANDOMIZED TRIAL | END-POINT REDUCTION | MYOCARDIAL FIBROSIS | PERIPHERAL VASCULAR DISEASE | ALDOSTERONE | SUPEROXIDE PRODUCTION | HEMATOLOGY | hypertension | SMOOTH-MUSCLE CELLS | Spironolactone - administration & dosage | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Enalapril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Adult | Female | Hypertrophy, Left Ventricular - drug therapy | Spironolactone - analogs & derivatives | Drug Therapy, Combination | Enalapril - administration & dosage | Amlodipine - administration & dosage | Spironolactone - therapeutic use | Mineralocorticoid Receptor Antagonists - administration & dosage | Double-Blind Method | Myocardium - pathology | Renin-Angiotensin System - physiology | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Hypertension - physiopathology | Amlodipine - therapeutic use | Mineralocorticoid Receptor Antagonists - therapeutic use | Drug Synergism | Magnetic Resonance Imaging | Potassium - blood | Renin-Angiotensin System - drug effects | Aged | Hypertrophy, Left Ventricular - physiopathology | Hydrochlorothiazide - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Hypertension, ISSN 0194-911X, 07/2019, Volume 74, Issue 1, pp. 56 - 62
In the PAMELA study (Pressioni Arteriose Monitorate e Loro Associazioni), clinical variables, an echocardiogram, as well as office and ambulatory blood... 
blood pressure | UNCONTROLLED HYPERTENSION | WHITE-COAT | PROGNOSTIC VALUE | follow-up studies | GENERAL-POPULATION | masked hypertension | OFFICE | DISEASE | PERIPHERAL VASCULAR DISEASE | risk | humans | ASSOCIATION | AMBULATORY BLOOD-PRESSURE | HOME | GEOMETRY | Hypertension | Diagnosis | Heart enlargement | Health aspects | Risk factors | Heart ventricle, Left
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 09/2014, Volume 130, Issue 18, pp. 1607 - 1616
Journal Article